GENEVA--(BUSINESS WIRE)--Alcon (SIX/NYSE:ALC), the global leader in eye care, reported its financial results for the fourth quarter and full year ended December 31, 2020. For the fourth quarter of ...

Former Novartis subsidiary Alcon, after targeting the pharmaceutical eye drop scene with a trio of recent drug purchases, is adding another pair of arrows to its ophthalmic quiver. And this time, the ...

ZURICH, Nov 27 (Reuters) - Novartis eye care unit Alcon, being spun off to investors next year, aims to pay a dividend from 2020 and will focus on "bolt-on" acquisitions to help boost core operating ...

Alcon (NYSE:ALC) is scheduled to announce Q4 earnings results on Tuesday, February 23rd, after market close. The consensus EPS Estimate is $0.41 (-8.9% Y/Y) and the consensus Revenue Estimate is ...

Refer to the associated explanatory footnotes at the end of the 'Reconciliation of IFRS to Core Results' tables. Separation costs are expected to be incurred over the two to three-year period ...